Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α Blockers

Stopped Due to delay in the study and the impact on the development timelines, not due to any identified safety concerns

Conditions

• Rheumatoid Arthritis

Interventions

• DRUG: Sarilumab
• DRUG: Placebo
• DRUG: Golimumab
• DRUG: methotrexate (MTX)
• DRUG: Folic/folinic acid

Sponsor

Sanofi

Collaborators

• [object Object]